Drugs / Kallikrein
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04102956 | Jul 2017 → Mar 2019 | ischemic stroke | The Second Hospital of Hebei Medical University | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kallikrein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04102956 ↗ |
| Route | Intravenous | “through intravenous injection” NCT04102956 ↗ |